Updated Nov. 19, 2009 at 8:33 a.m.
Salix
Salix goes to market with 5.5 million shares
Post a comment
Print this blog postE-mail blog post
Share
Salix
Related Blog Posts
- Revenues surge at Salix; quarterly performance tops Street expectations
- Salix pays $5M to Indian firm in deal to develop new version of diarrhea drug
- Positive drug trial news sends Salix shares soaring more than 51%
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter
Local Tech Wire
MORRISVILLE, N.C. — Drug-maker Salix Pharmaceuticals Ltd. (Nasdaq: SLXP) is offering 5.5 million new shares, the company said Wednesday. Salix set an opening price of $21 per share.
Current shares closed at $22 on Wednesday, their highest price since a stock split in 2004.
Salix said in a filing with the federal Securities and Exchange Commission that the sale will raise funds for business development and operations.
Analysts are forecasting strong sales growth over the next several financial quarters for Salix, which focuses on treatments for gastrointestinal diseases.
Jefferies & Company, Inc., is the underwriter.
Featured
Hot Off The Wire
- Hot Off the Wire – Google slashes Nexus One termination fee; MySpace Music tunes up audio ads; Barry Diller’s IAC beats Street
- Hot Off the Wire – Man convicted in first economic espionage case; iPhone market share grows; Electronic Arts shares falter after revenue forecast; Phone company wants to charge Google
- FairPoint looks to cut debt by two thirds with bankruptcy plan
E-mail Preferences
The Skinny
- Gears of War 3 coming? EA discloses Epic game for 2011
- Nagoya University bridges East, West with Nu Tech event
- E-mail services provider iContact investigating a hack attack
- Cyberespionage? Cyberslueths disclose Lenovo’s 2010 ‘roadmap’
- Tech recovery is at hand, analysts tells N.C. IT execs
- Believe it - Triangle region lands record $1.9B in business projects
- Epic Games’ heroes take their guns to a new world – ‘Lost Planet 2’
- IPO rewards: Motricity CEO gets a $75,000 raise in new contract
- IT recession over? Spending will rebound, analysis firm says
- Google vs. the Dragon – War over words could ignite into flames